Hypothesis

Telomere attrition in aged hematopoietic stem cells (HSCs) does not merely limit replicative capacity; it reflects an increase in epigenetic informational entropy that drives a maladaptive metabolic shift toward oxidative phosphorylation (OXPHOS), elevating ROS and impairing erythropoietin (EPO) responsiveness. Restoring telomere length reduces epigenetic entropy, normalizes mitochondrial function, and rescues EPO‑dependent erythroid differentiation.

Mechanistic Rationale

• Telomere shortening triggers chromatin relaxation and increased stochastic gene expression, quantifiable as rises in transcriptome entropy (Shannon entropy of RNA‑seq profiles).
• Elevated entropy destabilizes the expression of metabolic regulators (e.g., PGC‑1α, FOXO3), biasing HSCs toward high OXPHOS and ROS production.
• This metabolic state exacerbates DNA damage signaling, creating a feedback loop that further erodes telomeres and entropy.
• The aged niche amplifies this loop via inflammatory cytokines (IL‑6/SOCS3) that suppress glycolysis, reinforcing OXPHOS dependence.

Testable Predictions

1. In murine aged HSCs, telomere length will inversely correlate with single‑cell transcriptome entropy (higher entropy in short‑telomere cells).
2. Forced telomere elongation (via TERT overexpression or CRISPR‑based telomere repeat addition) will decrease transcriptome entropy, reduce OXPHOS/ROS ratios, and improve EPO‑induced STAT5 phosphorylation.
3. Pharmacological reduction of entropy (using HDAC inhibitors that stabilize chromatin) will mimic telomere elongation effects on metabolism without altering telomere length.
4. Conversely, inducing telomere damage in young HSCs will raise entropy, shift metabolism to OXPHOS, and diminish EPO sensitivity, even in a youthful niche.

Experimental Approach

• Isolate Lin⁻Sca‑1⁺c‑Kit⁺ (LSK) cells from young (3 mo) and aged (24 mo) mice.
• Measure telomere length (Q‑FISH) and perform scRNA‑seq to compute per‑cell transcriptome entropy.
• Transduce aged LSKs with a TERT‑expressing lentivirus; include controls (empty vector, catalytically dead TERT).
• Assess mitochondrial mass (MitoTracker), OXPHOS (Seahorse ATP production), ROS (MitoSOX), and EPO‑STAT5 signaling (phospho‑flow).
• Perform parallel experiments treating young LSKs with telomere‑targeting CRISPR‑Cas9 nickases to induce shortening.
• Use HDACi (e.g., vorinostat low dose) to test entropy‑reduction independent of telomere length.

Potential Outcomes and Falsifiability

• Support: Telomere elongation lowers entropy, normalizes OXPHOS/ROS, and restores EPO response; HDACi yields similar metabolic rescue; induced telomere shortening in young cells recapitulates aged phenotype.
• Refutation: Telomere manipulation fails to alter transcriptome entropy or metabolic/EPO readouts, indicating telomere length is not a determinant of epigenetic entropy in this context.

This framework links telomere biology to information theory and metabolic regulation, offering a concrete, falsifiable path to test whether telomere length serves as a read‑out of epigenetic entropy that governs the metabolic decline of erythropoiesis in aging.